The week in health tech, explained in plain English.Get the free newsletter →
September 20, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Medical Groups

ADHD Treatment's Next Frontier: The Full Active Day

ADHD care is entering a new phase where success is measured not just by whether a medication works, but by how long and how well it fits into a patient's real day. According to MedCity News, the next evolution in ADHD therapy must align treatment with the busy, demanding lives of patients, families, and caregivers rather than focusing narrowly on drug efficacy.

In practice, that means confronting a familiar problem: many stimulant and non-stimulant regimens control symptoms during the morning and midday but fade by late afternoon and evening. Those are exactly the hours when patients face homework, chores, family interactions, and driving, moments when lapses in focus and impulse control carry real consequences.

The implication for drugmakers and prescribers is a stronger emphasis on longer-acting formulations, flexible dosing, and treatment plans built around the full active day. For readers, the signal is that duration and daily-life fit are becoming as important as peak efficacy in how ADHD therapies are designed, evaluated, and marketed.

More in Medical Groups

Medical Groups

The Hidden Cost of Manual Work in Ambulatory Care

Manual administrative work is quietly draining time, capacity, and revenue from ambulatory practices, pushing many toward automation.

Why it matters: In low-margin outpatient care, hours lost to manual paperwork translate directly into fewer patients seen and slower revenue.

Medical Groups

Practices Turn to AI to Fight Rising Payer Denials

Rising payer denials and downcoding are pushing medical practices to adopt AI tools that flag and appeal problem claims before revenue is lost.

Why it matters: Unchallenged denials and downcoding erode already-thin practice margins, and AI is emerging as the practical way to recover that lost revenue.